GLP3 Planner

GLP3 Planner is a compound tracking tool designed specifically for GLP-3 receptor agonists, including Retatrutide, Semaglutide (Ozempic®/Wegovy®), and Tirzepatide (Mounjaro®/Zepbound®). Our advanced dose calculator helps you visualize drug concentrations in your system over time, enabling better treatment management and optimization. Read more about why we created GLP3 Planner here.

How It Works

Simply enter your compound type, dosing schedule, and administration times. GLP3 Planner calculates the concentration levels using established pharmacokinetic principles, showing you exactly how much compound remains active in your system at any given time. This helps you and your healthcare provider make informed decisions about dose adjustments and timing.

Key Features

• Precise Dose Calculations: Uses pharmacokinetic modeling based on each compound's half-life to accurately predict drug levels
• Multi-Compound Support: Track Retatrutide, Semaglutide, and Tirzepatide with compound-specific parameters
• Visual Tracking: Interactive graphs show compound levels over time, helping identify peak and trough concentrations
• Stability Analysis: Determine when your compound reaches steady-state levels for optimal therapeutic effect
• Weight Tracking: Monitor your weight progress alongside your dosage schedule
• Schedule Management: Save and manage multiple dosing schedules with secure cloud storage
• Calendar View: Visualize daily drug amounts in an intuitive calendar format NEW!
• Journal Entries: Track personal notes and observations alongside your dosage data NEW!
• Share Schedules: Securely share your dosage schedule NEW!

Support Us

If GLP3 Planner has helped you manage your journey, please consider supporting our development.

Important Note

GLP3 Planner is an educational tool designed to help visualize research compound pharmacokinetics. It should not replace professional medical advice. Always consult with your healthcare provider before making any changes to your medication regimen. The calculations are based on published half-life data and standard pharmacokinetic models, but individual responses may vary.